Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell TransMedics Group Inc (TMDX) – TransMedics Group Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

TransMedics Group (TMDX) is trading at $104.30, down 5.98% in the last session, with technical indicators showing a bearish bias. The company demonstrates strong fundamentals with a 31.43% net income margin and 54.24% ROE, having beaten earnings estimates for three consecutive quarters. Recent news highlights expansion of its organ preservation portfolio and upcoming Q1 2026 earnings report on May 5, 2026.
The stock presents a growth opportunity with 75% analyst buy ratings and a $151 consensus price target implying 45% upside, supported by strong revenue growth and expanding margins. Key risks include elevated valuation multiples (P/E 22.2, P/S 7.24), competitive pressures in medical technology, and execution challenges in clinical trial enrollment and market expansion.
Read full analysis

Key Stats

  • Market Cap
    $3.73B
  • Sector
    Technology
  • 3M Drawdown
    -36.28%
  • Enterprise Value
    $3.77B
  • Dividend Yield
    -
  • Typical Hold Time
    13 days
$102.26
52W Low: $89.98
02 May 2025
52W High: $150.42
01 Dec 2025

TransMedics Group Inc (TMDX) is currently valued at a market capitalization of $3.73B, with an enterprise value of $3.77B. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $89.98 and a high of $150.42, highlighting its annual price range. Over the past three months, TransMedics Group Inc has recorded a drawdown of -36.28%, reflecting recent price volatility. On average, investors hold TransMedics Group Inc for approximately 13 days, indicating typical investor behavior on the platform.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.


Technical Indicators
|
|
|
Overall Summary
Bearish (19)Neutral (1)Bullish (7)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $3.73B
  • Sector
    Technology
  • 3M Drawdown
    -36.28%
  • Enterprise Value
    $3.77B
  • Dividend Yield
    -
  • Typical Hold Time
    13 days
$102.26
52W Low: $89.98
02 May 2025
52W High: $150.42
01 Dec 2025

TransMedics Group Inc (TMDX) is currently valued at a market capitalization of $3.73B, with an enterprise value of $3.77B. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $89.98 and a high of $150.42, highlighting its annual price range. Over the past three months, TransMedics Group Inc has recorded a drawdown of -36.28%, reflecting recent price volatility. On average, investors hold TransMedics Group Inc for approximately 13 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!